Emi Nishida Selected Research

Emi Nishida Research Topics

Disease

10	Psoriasis (Pustulosis Palmaris et Plantaris) 01/2023 - 06/2011
4	Psoriatic Arthritis 01/2021 - 01/2017
3	Cutaneous T-Cell Lymphoma (Lymphoma, T Cell, Cutaneous) 07/2023 - 05/2020
3	Skin Diseases (Skin Disease) 02/2022 - 10/2011
3	Atopic Dermatitis (Atopic Eczema) 02/2021 - 07/2020
3	Neoplasms (Cancer) 11/2016 - 12/2008
2	Mycosis Fungoides 02/2022 - 06/2013
2	Sacroiliitis 01/2021 - 11/2019
2	Inflammation (Inflammations) 01/2019 - 06/2011
2	Acne Vulgaris 02/2009 - 02/2007
1	Overweight 07/2023
1	Hypertriglyceridemia 07/2023
1	Infections 01/2021
1	Ulcer 01/2021
1	Spondylitis 01/2021
1	Pyoderma Gangrenosum 01/2021
1	Hepatitis 01/2021
1	Autistic Disorder (Autism) 01/2021
1	Pruritus (Itching) 09/2020
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 09/2020
1	Mastocytoma 07/2020
1	Systemic Scleroderma (Systemic Sclerosis) 07/2020
1	Localized Scleroderma (Morphea) 07/2020
1	Ankylosing Spondylitis 01/2020
1	Hyperglycemia 01/2019
1	Hypercalcemia (Milk Alkali Syndrome) 08/2018
1	Bullous Pemphigoid (Pemphigoid) 04/2018
1	Pemphigoid Gestationis (Herpes Gestationis) 04/2018
1	Epidermolysis Bullosa Acquisita (Acquired Epidermolysis Bullosa) 04/2018
1	Autoimmune Diseases (Autoimmune Disease) 01/2017
1	Rheumatic Diseases (Rheumatism) 01/2017
1	Granuloma Annulare 11/2015
1	Insulin Resistance 06/2011
1	Pain (Aches) 02/2009
1	Erythema 02/2009

Drug/Important Bio-Agent (IBA)

4	Ficusin (Psoralen)IBA 02/2022 - 01/2013
3	Bexarotene (LGD1069)FDA Link 07/2023 - 05/2020
3	Adalimumab (Humira)FDA Link 01/2021 - 01/2017
3	Biomarkers (Surrogate Marker)IBA 09/2020 - 01/2017
2	dupilumabIBA 02/2021 - 09/2020
2	C-Reactive ProteinIBA 01/2020 - 01/2017
2	CytokinesIBA 04/2017 - 01/2017
1	Triglycerides (Triacylglycerol)IBA 07/2023
1	SuspensionsIBA 07/2023
1	LipidsIBA 07/2023
1	Aryl Hydrocarbon Receptors (Aryl Hydrocarbon Receptor)IBA 01/2023
1	SmokeIBA 01/2023
1	Air Pollutants (Pollutants, Air)IBA 01/2023
1	Aldo-Keto ReductasesIBA 01/2023
1	Methoxsalen (Oxsoralen)FDA Link 02/2022
1	Janus Kinase 1IBA 01/2021
1	Immunosuppressive Agents (Immunosuppressants)IBA 01/2021
1	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2021
1	Interleukin-13IBA 09/2020
1	CC ChemokinesIBA 09/2020
1	Interleukin-22 (IL-22)IBA 09/2020
1	PeriostinIBA 09/2020
1	Interleukin-2 Receptors (IL 2 Receptor)IBA 09/2020
1	Immunoglobulin E (IgE)IBA 09/2020
1	Thymic Stromal LymphopoietinIBA 09/2020
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 09/2020
1	LigandsIBA 09/2020
1	Interleukin-33IBA 09/2020
1	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 01/2020
1	HLA-B46 antigenIBA 11/2019
1	Imiquimod (Aldara)FDA LinkGeneric 01/2019
1	Monoclonal AntibodiesIBA 01/2019
1	Blood Glucose (Blood Sugar)IBA 01/2019
1	Interleukin-17 (Interleukin 17)IBA 01/2019
1	SteroidsIBA 08/2018
1	betamethasone-17,21-dipropionate (betamethasone dipropionate)FDA LinkGeneric 08/2018
1	Ointments (Pastes)IBA 08/2018
1	Cholecalciferol (Vitamin D3)FDA Link 08/2018
1	calcipotriene (calcipotriol)FDA LinkGeneric 08/2018
1	Proteins (Proteins, Gene)FDA Link 04/2018
1	Laminin (Merosin)IBA 04/2018
1	Immunoglobulins (Immunoglobulin)IBA 04/2018
1	Immunoglobulin A (IgA)IBA 04/2018
1	AutoantibodiesIBA 04/2018
1	AntibodiesIBA 04/2018
1	Ustekinumab (CNTO 1275)FDA Link 01/2017
1	Infliximab (Remicade)FDA Link 01/2017
1	InterleukinsIBA 01/2017
1	Interleukin-6 (Interleukin 6)IBA 01/2017
1	Indicators and Reagents (Reagents)IBA 01/2017
1	AdipokinesIBA 06/2011
1	LeptinIBA 06/2011
1	ResistinIBA 06/2011
1	Therapeutic UsesIBA 12/2008

Therapy/Procedure

10	Therapeutics 07/2023 - 02/2009
5	Phototherapy (Light Therapy) 07/2023 - 02/2007
2	Photochemotherapy (Photodynamic Therapy) 02/2022 - 01/2013
2	PUVA Therapy 04/2017 - 06/2013
1	Oral Administration 02/2022
1	Blood Component Removal (Apheresis) 01/2018
1	Drug Therapy (Chemotherapy) 11/2016
1	Semiconductor Lasers 02/2009
1	Lasers (Laser) 02/2009
1	Local Anesthesia 02/2009